• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.54% Nasdaq Down 0.84%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    139.33 Down 3.20(2.24%) 3:14PM EDT - Nasdaq Real Time Price
    Prev Close:142.53
    Open:141.88
    Bid:138.87 x 100
    Ask:139.05 x 400
    1y Target Est:197.21
    Beta:1.42705
    Earnings Date:Jul 28 - Aug 1 (Est.)
    Day's Range:137.40 - 142.30
    52wk Range:124.16 - 208.88
    Volume:1,499,359
    Avg Vol (3m):1,803,580
    Market Cap:31.31B
    P/E (ttm):207.96
    EPS (ttm):0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 2.24%31.31B
    AMGNDown 1.61%118.48B
    BAXDown 0.53%24.22B

    Key Statistics

    Forward P/E (1 yr):20.85
    P/S (ttm):12.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :5.11
    Quarterly EPS Est (Jun-16) :1.21
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.37

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback